A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women

NCT00774683 · clinicaltrials.gov ↗

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

HIV
AIDS

Interventions

DRUG: Raltegravir (Isentress®)

Sponsor

Kristine Patterson, MD

Collaborators

[object Object]